The EPS miss may cause short-term selling pressure, but the revenue beat, raised guidance, and continued profitability improvement (3rd consecutive positive adjusted EBITDA) support a bullish fundamental thesis. Watch for free cash flow positivity in H2 2026 as guided. Further adoption of the minimally invasive platform is a key catalyst.
Price Chart
Executive Summary
Establishment Labs reported Q2 2026 revenue of $67.5M (+31.7% YoY, beating $65.8M consensus) and raised full-year revenue guidance to $269M-$271M, but GAAP EPS of -$0.39 missed consensus -$0.30 by 30%. The company achieved its third consecutive quarter of positive adjusted EBITDA ($3.7M) and saw strong momentum in its minimally invasive platform. The EPS miss was driven by one-time debt refinancing and restructuring charges of $2.2M.
Key Financial Metrics
Key Facts
- Q2 2026 revenue $67.5M, up 31.7% YoY, beating consensus $65.8M by 2.65%
- GAAP EPS -$0.39, missing consensus -$0.30 by 30% (surprise -30%)
- Full-year 2026 revenue guidance raised to $269M-$271M from $266.5M-$268.5M
- Third consecutive quarter of positive adjusted EBITDA at $3.7M vs -$8.5M year ago
- Minimally invasive revenue reached $12.1M, up from $9.1M in Q1 2026
- Cash balance $71.2M, up $3.1M sequentially from Q1 2026
- One-time charges of $2.2M for debt refinancing and restructuring included in Q2
- Loss from operations improved to -$4.3M from -$14.1M year ago
Financial Impact
Revenue beat of $1.7M vs consensus, but EPS miss of $0.09 per share. Guidance raise implies ~$2.5M incremental full-year revenue. Adjusted EBITDA swung positive by $12.2M year-over-year.
Risk Factors
- GAAP net loss continues at -$11.7M for the quarter
- Operating cash flow remains negative (-$20.9M first half 2026)
- Execution risk on scaling the minimally invasive platform and achieving FCF positive
- Debt refinancing charges and restructuring costs may recur
- Foreign currency fluctuations could impact results
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001688757-26-000047 |
| Document: esta-20260806.htm | 0001688757-26-000047 |
| Document: 0001688757-26-000047-index-headers.html | 0001688757-26-000047 |
| Document: 0001688757-26-000047-index.html | 0001688757-26-000047 |
| Document: 0001688757-26-000047.txt | 0001688757-26-000047 |
| 8-K Data (Synthetic) | 0001688757-26-000047 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | 8-K | $61.36 | awaiting T+60 | — | $67.04 (+9.26%) |
Aug 6, 2026 11w ago | 8-K | $79.05 | awaiting T+60 | — | $67.04 (−15.19%) |
Jun 29, 2026 17w ago | 3 | $85.81 $67.76 | ▼ −21.03% | ▼ −23.85% | $67.04 (−21.87%) |
Jun 29, 2026 17w ago | 8-K | $87.42 $70.24 | ▼ −19.65% | ▼ −24.04% | $67.04 (−23.31%) |
May 6, 2026 24w ago | 8-K | $74.54 $92.54 | ▲ +24.15% | ▲ +22.09% | $67.04 (−10.06%) |
May 6, 2026 24w ago | Insider Cluster | $74.54 $92.54 | ▼ −24.15% | ▼ −22.09% | $67.04 (+10.06%) |
Apr 24, 2026 26w ago | DEFA14A | $65.47 $93.87 | ▲ +43.38% | ▲ +38.60% | $67.04 (+2.40%) |
Apr 10, 2026 28w ago | DEFA14A | $62.92 $87.99 | ▲ +39.84% | ▲ +30.92% | $67.04 (+6.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers